Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

394 results about "Tissue type" patented technology

There are four main tissue types: connective tissue, muscle tissue, nervous tissue, and epithelial tissue. These tissue types all work in conjunction to make a complete organism.

Active electrode, bio-impedance based, tissue discrimination system and methods of use

Systems and methods for discriminating and locating tissues within a body involve applying a waveform signal to tissue between two electrodes and measuring the electrical characteristics of the signal transmitted through the tissue. At least one of the electrodes is constrained in area so that localized electrical characteristics of the tissue are measured. Such localized electrical characteristics are determined over a portion of a body of the subject by using an array of electrodes or electrodes that can be moved over the body. A controller may implement the process and perform calculations on the measured data to identify tissue types and locations within the measured area, and to present results in graphical form. Results may be combined with other tissue imaging technologies and with image-guided systems.
Owner:NERVONIX INC

Method and system for knowledge guided hyperintensity detection and volumetric measurement

An automated method and / or system for identifying suspected lesions in a brain is provided. A processor (a) provides a magnetic resonance image (MRI) of a patient's head, including a plurality of slices of the patient's head, which MRI comprises a multispectral data set that can be displayed as an image of varying pixel intensities. The processor (b) identifies a brain area within each slice to provide a plurality of masked images of intracranial tissue. The processor (c) applies a segmentation technique to at least one of the masked images to classify the varying pixel intensities into separate groupings, which potentially correspond to different tissue types. The processor (d) refines the initial segmentation into the separate groupings of at least the first masked image obtained from step (c) using one or more knowledge rules that combine pixel intensities with spatial relationships of anatomical structures to locate one or more anatomical regions of the brain. The processor (e) identifies, if present, the one or more anatomical regions of the brain located in step (d) in other masked images obtained from step (c). The processor (f) further refines the resulting knowledge rule-refined images from steps (d) and (e) to locate suspected lesions in the brain.
Owner:UNIV OF SOUTH FLORIDA

Placental derived stem cells and uses thereof

The present invention features novel placental derived stem cells and provides methods and compositions for the therapeutic uses of placental derived stem cells or placental derived stem cells that have been induced to differentiate into a desired tissue type into a recipient host in amounts sufficient to result in production of the desired cell type, i.e., hepatic, pancreatic, neuronal, or nervous tissue.
Owner:UNIVERSITY OF PITTSBURGH

Apparatus for recognizing tissue types

InactiveUS6845264B1Remove the ambiguity of any one measurementPerson identificationSurgical instruments for heatingPower flowMedicine
A method and apparatus for recognizing tissue types measures at least two separate and distinct properties of a tissue specimen using a probe tip containing electrodes coupled to circuitry that applies a measuring current and obtains values of electrical properties of the tissue such as conductivity and potential difference. An algorithm then uses the values to determine the tissue's type and condition.
Owner:SKLADNEV VICTOR +2

Tissue biopsy and treatment apparatus and method

A method of treating a tumor includes providing a tissue biopsy and treatment apparatus that includes an elongated delivery device that has a lumen and is maneuverable in tissue. A sensor array having a plurality of resilient members is deployable from the elongated delivery device. At least one of the plurality of resilient members is positionable in the elongated delivery device in a compacted state and deployable with curvature into tissue from the elongated delivery device in a deployed state. At least one of the plurality of resilient members includes at least one of a sensor, a tissue piercing distal end or a lumen. The sensor array has a geometric configuration adapted to volumetrically sample tissue at a tissue site to differentiate or identify tissue at the tissue site. At least one energy delivery device is coupled to one of the sensor array, at least one of the plurality of resilient members or the elongated delivery device. The apparatus is then introduced into a target tissue site. The sensor array is then utilized to distinguish a tissue type. The tissue type information derived from the sensor array is utilized to position the energy delivery device to ablate a tumor volume. Energy is then delivered from the energy delivery device to ablate or necrose at least a portion of the tumor volume. The sensor array is then utilized to determine an amount of tumor volume ablation.
Owner:ANGIODYNAMICS INC

Method and apparatus for determining local tissue impedance for positioning of a needle

The invention relates to apparatus and methods for measuring local tissue impedance for subcutaneous tissue surrounding a needle tip inserted into a subject, impedance spectra and / or complex impedance values are determined. The invention applies a monopolar impedance measuring setup with a needle, a current-carrying electrode, an optional reference electrode. The setup is configured to eliminate contributions from the current-carrying electrode in order to measure local impedance of tissue in the close neighbourhood of the needle tip instead of an averaged value over the volume or current path between the needle and the electrode(s). The determined impedance can be correlated with either a tissue type or state, or with a position of the needle tip in the subject, and can thereby provide an insertion history to the operator in the form of impedance or corresponding tissue type as a function of insertion depth or time.
Owner:UNIV OSLO HF

System and method of characterizing vascular tissue

A system and method is provided for using backscattered data and known parameters to characterize vascular tissue. Specifically, in one embodiment of the present invention, an ultrasonic device is used to acquire RF backscattered data (i.e., IVUS data) from a blood vessel. The IVUS data is then transmitted to a computing device and used to create an IVUS image. The blood vessel is then cross-sectioned and used to identify its tissue type and to create a corresponding image (i.e., histology image). A region of interest (ROI), preferably corresponding to the identified tissue type, is then identified on the histology image. The computing device, or more particularly, a characterization application operating thereon, is then adapted to identify a corresponding region on the IVUS image. To accurately match the ROI, however, it may be necessary to warp or morph the histology image to substantially fit the contour of the IVUS image. After the corresponding region is identified, the IVUS data that corresponds to this region is identified. Signal processing is then performed and at least one parameter is identified. The identified parameter and the tissue type (e.g., characterization data) is stored in a database. In another embodiment of the present invention, the characterization application is adapted to receive IVUS data, determine parameters related thereto (either directly or indirectly), and use the parameters stored in the database to identify a tissue type or a characterization thereof.
Owner:THE CLEVELAND CLINIC FOUND

System and method for vascular border detection

A system and method is provided for using the frequency spectrum of a radio frequency (RF) signal backscattered from vascular tissue to identify at least one border (e.g., tissue interface, etc.) on a vascular image. Embodiments of the present invention operate in accordance with a data gathering device (e.g., an intra-vascular ultrasound (IVUS) device, etc.) electrically connected to a computing device and a transducer via a catheter. The transducer is used to gather radio frequency (RF) data backscattered from vascular tissue. The RF data is then provided to (or acquired by) the computing device via the data-gathering device. In one embodiment of the present invention, the computing device includes (i) at least one data storage device (e.g., database, memory, etc.) for storing a plurality of tissue types and parameters related thereto and (ii) at least one application (e.g., a characterization application, a gradient-border application, a frequency-border application and / or an active-contour application). The characterization application is used to convert (or transform) the RF data into the frequency domain and to identify a plurality of parameters associated therewith. The identified parameters are then compared to the parameters stored in the data storage device to identify the corresponding tissue type. This information (e.g., tissue type, corresponding RF data, etc.) is then used, either alone or together with other border-related information (e.g., gradient information, other-border information, etc.), to determine at least one border on a vascular image.
Owner:THE CLEVELAND CLINIC FOUND

System and method for determining tissue type and mapping tissue morphology

A method and system for determining tissue type is provided. The system comprises an electronic control unit (ECU) configured to acquire a value of an electrical parameter between a first electrode electrically coupled with tissue and a second electrode. The ECU is further configured to identify a tissue type from a plurality of tissue types based at least on the acquired value, and in an exemplary embodiment, to generate a tissue morphology map comprising a marker representative of the identified tissue type. The method comprises acquiring a value of an electrical parameter between a first electrode electrically coupled with tissue and a second electrode. The method further comprises identifying a tissue type from a plurality of tissue types based on at least the acquired value of the electrical parameter, and in an exemplary embodiment, the method further comprises generating a tissue morphology map based on the identified tissue type.
Owner:ST JUDE MEDICAL ATRIAL FIBRILLATION DIV

Liposuction system

ActiveUS20090192441A1Minimize inertiaStopping actionElectrotherapyChiropractic devicesLiposuctionEngineering
A surgical tool such as a liposuction cannula is equipped with a sensor at the tool tip. The sensor continuously analyzes the type of tissue in contact with the tip based on the electrical properties of the tissue. When encountering a tissue type that should not be disturbed, the action of the surgical tool is stopped automatically. When used for liposuction, the cannula is mechanically decoupled from the handle when the wrong type of tissue is detected thus minimizing the inertia of the part that needs to be stopped. Besides electrical sensing, other sensors, such as mechanical or ultrasonic, can be used at the tip of the surgical tool or cannula to differentiate between tissue types
Owner:KARDIUM

Endoscopic instrument for tissue identification

The present disclosure relates to various apparatus, systems and methods of identifying and treating tissue using at least one electrical property of tissue. Provided is a method for identifying and treating tissue, the method including providing a electrosurgical treatment device including an electrode assembly for measuring one or more electrical properties of a target tissue, the electrode assembly being mounted on a distal end thereof, measuring the one or more electrical characteristics of the target tissue, comparing the measured electrical property values of the target tissue against electrical property values of known tissue types, identifying a tissue type of the target tissue, adjusting an energy delivery configuration of the electrosurgical treatment device to the type of target tissue, and activating the electrosurgical treatment device to treat the target tissue.
Owner:TYCO HEALTHCARE GRP LP

Displaying image data using automatic presets

A computer automated method that applies supervised pattern recognition to classify whether voxels in a medical image data set correspond to a tissue type of interest is described. The method comprises a user identifying examples of voxels which correspond to the tissue type of interest and examples of voxels which do not. Characterizing parameters, such as voxel value, local averages and local standard deviations of voxel value are then computed for the identified example voxels. From these characterizing parameters, one or more distinguishing parameters are identified. The distinguishing parameter are those parameters having values which depend on whether or not the voxel with which they are associated corresponds to the tissue type of interest. The distinguishing parameters are then computed for other voxels in the medical image data set, and these voxels are classified on the basis of the value of their distinguishing parameters. The approach allows tissue types which differ only slightly to be distinguished according to a user's wishes.
Owner:VOXAR

Determination of feature boundaries in a digital representation of an anatomical structure

A virtual anatomical structure can be analyzed to determine enclosing three-dimensional boundaries of features therein. Various techniques can be used to determine tissue types in the virtual anatomical structure. For example, tissue types can be determined via an iso-boundary between lumen and air in the virtual anatomical structure and a fuzzy clustering approach. Based on the tissue type determination, a deformable model approach can be used to determine an enclosing three-dimensional boundary of a feature in the virtual anatomical structure. The enclosing three-dimensional boundary can be used to determine characteristics of the feature and classify it as of interest or not of interest.
Owner:UNITED STATES OF AMERICA

Tissue biopsy and treatment apparatus and method

A method of treating a tumor includes providing a tissue biopsy and treatment apparatus that includes an elongated delivery device that has a lumen and is maneuverable in tissue. A sensor array having a plurality of resilient members is deployable from the elongated delivery device. At least one of the plurality of resilient members is positionable in the elongated delivery device in a compacted state and deployable with curvature into tissue from the elongated delivery device in a deployed state. At least one of the plurality of resilient members includes at least one of a sensor, a tissue piercing distal end or a lumen. The sensor array has a geometric configuration adapted to volumetrically sample tissue at a tissue site to differentiate or identify tissue at the tissue site. At least one energy delivery device is coupled to one of the sensor array, at least one of the plurality of resilient members or the elongated delivery device. The apparatus is then introduced into a target tissue site. The sensor array is then utilized to distinguish a tissue type. The tissue type information derived from the sensor array is utilized to position the energy delivery device to ablate a tumor volume. Energy is then delivered from the energy delivery device to ablate or necrose at least a portion of the tumor volume. The sensor array is then utilized to determine an amount of tumor volume ablation.
Owner:ANGIODYNAMICS INC

Selective Accumulation of Energy With or Without Knowledge of Tissue Topography

ActiveUS20100125268A1Avoids significant thermal damageSignificant thermal damageUltrasound therapyChiropractic devicesPulse energyPulse characteristics
Methods and systems for heating a body tissue region adjacent a body lumen with diseased and healthy portions using selective accumulation of energy in the artery tissue with or without knowledge of tissue topography. The method includes positioning an energy delivery portion of a catheter body within the lumen adjacent the body tissue region to be heated, determining a pulse characteristic in response to a thermal property of a first tissue type and applying pulsed energy with the pulse characteristic from the energy delivery portion so as to therapeutically treat the second tissue type within the body tissue region by drawing heat from the first tissue type at a rate that avoids significant thermal damage to the first tissue type while building-up heat in the second tissue type. The system includes an elongate flexible catheter body having a proximal end and a distal end with an axis therebetween, an energy delivery portion proximate the distal end, an energy source coupled to the energy delivery portion and a processor coupled to the energy source, the processor configured to control a pulse characteristic of pulsed energy transmitted from the energy source to the energy delivery portion so as to therapeutically treat the second tissue type within the body tissue region by drawing heat from the first tissue type at a rate that avoids significant thermal damage to the first tissue type while building-up heat in the second tissue type.
Owner:BOSTON SCI SCIMED INC

Determining biological tissue type

ActiveUS10716489B2Improve accuracySimple and reliable techniqueDiagnostic recording/measuringSensorsComplex impedance spectraData set
A method is described for determining biological tissue type based on a complex impedance spectra obtained from a probe with a conducting part adjacent a tissue region of interest, wherein the impedance spectra includes data from a number of frequencies. The method may include: obtaining, from the complex impedance spectra, a first data set representative of impedance modulus values, or equivalent admittance values, at one or more frequencies, obtaining, from the complex impedance spectra, a second data set representative of impedance phase angle values, or equivalent admittance values, at one or more different frequencies, applying a first discrimination criterion to the first data set, applying a second discrimination criterion to the second data set, and thereby determining if the tissue region of interest is a tissue type characterised by the discrimination criteria.
Owner:UNIV OSLO HF

System and method for identification of biological tissues

The present invention provides for a system, method, and device for analyzing, localizing and / or identifying tissue types. The method includes analyzing, localizing and / or identifying one or more tissue samples, characterized in that the method comprises: (a) generating gaseous tissue particles from a site in the one or more tissue samples, (b) transporting the gaseous tissue particles from the site to an analyser, (c) using the analyser for generating tissue-related data based on the gaseous tissue particles, and (d) analyzing, localizing and / or identifying the one or more tissue samples based on the tissue-related data. The invention can either be used in close conjunction with a surgical procedure, when one or more surgical tools are an integrated part of ionization, or as a separate mass spectrometric probe for the analysis of one or more tissue parts.
Owner:MICROMASS UK LTD +1

Method and apparatus for calculating blood flow parameters

A method for determining tissue type includes quantitatively determining a tissue blood flow (TBF) by deconvoluting Q(t) and Ca(t), where Q(t) represents a curve of specific mass of contrast, and Ca(t) represents an arterial curve of contrast concentration, and quantitatively determining a tissue blood volume (TBV) by deconvoluting Q(t) and Ca(t). The method also includes quantitatively determining a tissue mean transit time (TMTT) by deconvoluting Q(t) and Ca(t), and quantitatively determining a tissue capillary permeability surface area product (TPS) by deconvoluting Q(t) and Ca(t). The method also includes determining a tissue type based on the TBF, the TBV, the TMTT, and the TPS.
Owner:THE JOHN P ROBARTS RES INST

Clean margin assessment tool

An integrated tool is provided, having a tissue-type sensor, for determining the tissue type at a near zone volume of a tissue surface, and a distance-measuring sensor, for determining the distance to an interface with another tissue type, for (i) confirming an existence of a clean margin of healthy tissue around a malignant tumor, which is being removed, and (ii) determining the depth of the clean margin. The integrated tool may further include a position tracking device and an incision instrument. The soft tissue may be held within a fixed frame, while the tumor is being removed. Additionally a method for malignant tumor removal is provided, comprising, fixing the soft tissue within a frame, performing imaging with the hand-held, integrated tool, from a plurality of locations and orientations around the soft tissue, reconstructing a three-dimensional image of the soft tissue and the tumor within, defining a desired clean margin on the reconstructed image, calculating a recommended incision path, displaying the recommended path on the reconstructed image, and cutting the tissue while determining its type, at the near zone volume of the incision surface. The method may further include continuously imaging with the cutting, continuously correcting the reconstructed image and the recommended incision path, and continuously determining the tissue type, at the near zone volume of the incision surface.
Owner:DUNE MEDICAL DEVICES

Delivery system using mAb 3E10 and mutants and/or functional fragments thereof

A monoclonal antibody, 3E10, and active fragments thereof that selectively are transported in vivo to the nucleus of mammalian cells without cytotoxic effect are provided. The antibody and other molecules that bind to a variant of myosin IIb heavy chain found in the nucleus of skeletal muscle cells are useful as a non-viral delivery vector to target skeletal muscle in vivo. By contrast, in vitro the monoclonal antibody penetrates and is transported to the nucleus of multiple cell lines derived from different tissue types and can be used in screening tests to identify molecules that modulate growth of cells, such as cancer cells. Non-cytotoxic vectors for delivering a drug, polynucleotide or polypeptide selectively to skeletal muscle cells are also provided.
Owner:U S GOVERNMENT REPRESENTED BY THE DEPT OF VETERANS AFFAIRS +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products